Antinuclear antibodies.
D000818:Animals; D000974:Antibodies, Antinuclear / Q000302:isolation & purification; D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001324:Autoantigens; D003601:Cytotoxicity Tests, Immunologic; D004247:DNA; D005455:Fluorescent Antibody Technique; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007104:Immune Adherence Reaction; D007538:Isoniazid / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000276:immunology* / Q000662:veterinary; D008750:Methyldopa / Q000009:adverse effects; D009393:Nephritis / Q000276:immunology; D009504:Neutrophils; D009698:Nucleoproteins; D011342:Procainamide / Q000009:adverse effects; D012859:Sjogren's Syndrome / Q000276:immunology
D000974:Antibodies, Antinuclear; D001324:Autoantigens; D009698:Nucleoproteins; D006830:Hydralazine; D008750:Methyldopa; D004247:DNA; D011342:Procainamide; D007538:Isoniazid